The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

spirationinc.com

Founded Year

1999

Stage

Acquired | Acquired

Total Raised

$108.45M

About Spiration

Spiration was founded to develop treatments for chronic obstructive pulmonary disease.

Spiration Headquarter Location

6675 185th Avenue NE

Redmond, Washington, 98052,

United States

425-497-1700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Spiration

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Spiration is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,383 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Spiration Patents

Spiration has filed 131 patents.

The 3 most popular patent topics include:

  • Medical equipment
  • Endoscopy
  • Surgery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/16/2017

4/5/2022

Capacitors, Medical equipment, Seabird colonies, Fluid dynamics, Lithics

Grant

Application Date

3/16/2017

Grant Date

4/5/2022

Title

Related Topics

Capacitors, Medical equipment, Seabird colonies, Fluid dynamics, Lithics

Status

Grant

Latest Spiration News

Anthem Blue Cross And Blue Shield Adds Coverage For Severe Emphysema Treatment

Sep 30, 2021

Anthem Blue Cross And Blue Shield Adds Coverage For Severe Emphysema Treatment Minimally Invasive Spiration® Valve System Now Available to Blue Cross Blue Shield Members in 14 States Author: Sep 30, 2021 10:17 AM EDT CENTER VALLEY, Pa., Sept. 30, 2021 /PRNewswire/ -- Olympus today announced that Anthem Blue Cross Blue Shield, the second largest commercial health plan in the country, has updated their coverage policy to include the Spiration Valve System for patients suffering from severe emphysema, a form of COPD (Chronic Obstructive Pulmonary Disease). This follows positive coverage decisions by other BCBS plans, extending coverage for endobronchial valve therapy in the U.S. The Spiration Valve System provides a minimally invasive treatment that has been shown to improve lung function and reduce breathlessness for eligible patients who are suffering from the debilitating symptoms of severe emphysema. i Anthem is the largest independent licensee of the Blue Cross and Blue Shield Association, covering more than 33 million lives through their commercial and governmental plan types. ii The new commercial policy covers beneficiaries across 14 states: California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, New Hampshire, Nevada, New York, Ohio, Virginia and Wisconsin. iii This positive coverage decision adds to a growing list of insurance companies that now cover endobronchial valve treatment, including Blue Cross and Blue Shield Association licensees Highmark and Health Care Service Corporation, Blue Cross Blue Shield North Carolina, Massachusetts, Michigan and North Dakota, Aetna, and Humana. "This decision by Anthem will provide expanded access to a critical new therapy for patients suffering the breathlessness that comes with severe emphysema," said Lynn Ray, Vice President and General Manager of the Global Respiratory Business Unit for Olympus Corporation. "Olympus is very proud of its role in developing minimally invasive treatment options that provide an alternative to open surgery, which can further compromise patients who are already vulnerable with a chronic condition like emphysema." "Clinical trials have proven that bronchoscopic lung volume reduction (BLVR) with endobronchial valves demonstrates statistically significant and clinically meaningful improvements in lung function, reduction in shortness of breath and improvement in quality of life compared to standard of care medical management," said Dr. Grant Pierson, Pulmonologist with Freeman Health System in Joplin, MO. iv,v For information about the Spiration Valve System, visit these dedicated websites: For patients and their families:  https://svs.olympusamerica.com/patients-and-family Full prescriptive information:  https://svs.olympusamerica.com/prescriptive-information About Olympus Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries. Olympus' Medical business uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of EndoTherapy instruments. For more information, visit www.medical.olympusamerica.com . i Prescriptive Information. svs.olympusamerica.com. https://svs.olympusamerica.com/prescriptive-information . Published March 2019. Accessed September 14, 2021.  ii Data Sourced by Policy Reporter, a TrialCard Company. Accessed August 31, 2021. iii Stats & Facts. Antheminc.com. https://www.antheminc.com/NewsMedia/FrequentlyRequestedMaterials/StatsFacts/index.htm. Published 2020. Accessed September 22, 2021. iv Criner GJ, Delage A, Voelker K, et al. "Improving lung function in severe heterogenous emphysema with the Spiration® Valve System (EMPROVE): a multicenter, open-label, randomized, controlled trial." American Journal of Respiratory and Critical Care Medicine. 2019;200(11):1354-1362, 2019 v Wang G, Li S, Wang C, et. al. The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results. European Respiratory Journal. 2017; 50(61); DOI: 10.1183/1393003.congress-2017.OA1465 View original content to download multimedia: https://www.prnewswire.com/news-releases/anthem-blue-cross-and-blue-shield-adds-coverage-for-severe-emphysema-treatment-301388970.html SOURCE Olympus Medical Systems Group By

  • When was Spiration founded?

    Spiration was founded in 1999.

  • Where is Spiration's headquarters?

    Spiration's headquarters is located at 6675 185th Avenue NE, Redmond.

  • What is Spiration's latest funding round?

    Spiration's latest funding round is Acquired.

  • How much did Spiration raise?

    Spiration raised a total of $108.45M.

  • Who are the investors of Spiration?

    Investors of Spiration include Olympus Corporation, Olympus Corporation of the Americas, Versant Ventures, New Enterprise Associates, Three Arch Partners and 8 more.

  • Who are Spiration's competitors?

    Competitors of Spiration include CVRx, TxCell, Conatus Pharmaceuticals, Advanced Biohealing, Arginetix and 9 more.

You May Also Like

A
Asterion

Asterion is a manufacturer of analog semiconductors.

I
Intarcia Therapeutics

Intarcia Therapeutics is a biopharmaceutical company based in Boston, Massachusetts. Intarcia is engaged in the development of a pipeline of products for the proprietary Medici Drug Delivery System comprised of three technologies: A stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures, a matchstick-sized osmotic mini-pump that is placed under the dermal layer of skin to deliver a continuous and consistent flow of medication, and a placement technology including proprietary tools designed to provide an optimal user experience.

A
Alacrity Biosciences

Alacrity Biosciences is a biopharmaceutical company focused on acquiring, developing and commercializing therapeutics to treat ophthalmic diseases that threaten vision and reduce patient quality of life.

A
Antipodean

Antipodean is a pharmaceutical company developing treatments for neurodegenerative diseases such as Parkinson's Disease and Friedreich's Ataxia that are associated with mitochondrial dysfunction.

H
Humanetics Corporation

Humanetics Corporation is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs with a focus on radiation modulators for oncology, medical imaging and medical countermeasure uses.

I
ISW Group

ISW Group is a pharmaceutical company that researches and aims to develop FDA approved topical products for the management and treatment of acute and chronic inflammatory skin conditions. ISW Group's research program focuses on acute and chronic dermatologic irritation and inflammation associated with dermatitis, Pseudofolliculitis barbae, burn care and wound healing.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.